Search

Glaukos Corp

Fechado

SetorSaúde

159.86 3.99

Visão Geral

Variação de preço das ações

24h

Atual

Mín

153.72

Máximo

155.13

Indicadores-chave

By Trading Economics

Rendimento

1.4M

-18M

Vendas

35M

186M

EPS

-0.14

Margem de lucro

-9.901

Funcionários

1,094

EBITDA

-1.6M

-6.9M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+27.78% upside

Dividendos

By Acuity

Próximos Ganhos

28 de out. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

605M

9.5B

Abertura anterior

155.87

Fecho anterior

159.86

Sentimento de Notícias

By Acuity

60%

40%

254 / 339 Ranking em Healthcare

Glaukos Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de set. de 2026, 20:07 UTC

Glaukos Corp shares fell sharply, closing just below Thursday's close and approximately 9.45% below their 20-day moving average.

23 de set. de 2026, 20:01 UTC

News

Glaukos Corporation launched a keratoconus awareness campaign with Stephen Curry, but shares fell sharply today, continuing a trend of three consecutive daily declines.

22 de set. de 2026, 23:01 UTC

Glaukos Corp is advancing in after-market trading, reflecting a directional move since Tuesday's close, though it remains 6.99% below its 20-day moving average.

21 de set. de 2026, 20:06 UTC

Glaukos Corp's shares are declining, remaining below their 20-day moving average and near the lower end of their one-month range despite an earlier session recovery.

18 de set. de 2026, 20:02 UTC

Glaukos Corp is advancing during market hours on Friday, continuing its upward trend since Thursday's close, despite lower trading compared to earlier sessions.

17 de set. de 2026, 19:36 UTC

Glaukos Corp shares fell sharply, currently at their lowest point of the day and significantly below the 20-day moving average.

16 de set. de 2026, 19:03 UTC

Glaukos Corp shares fell sharply, reversing a trend of higher daily closes, amid unusually high market volume on Wednesday.

14 de set. de 2026, 19:16 UTC

Glaukos Corp shares are higher today, despite no specific news, following three consecutive sessions of declines. The stock remains below its 20-day moving average.

11 de set. de 2026, 20:08 UTC

Glaukos Corp shares are lower today, continuing a decline over the past four sessions and trading below the 20-day moving average.

10 de set. de 2026, 20:03 UTC

Glaukos Corp shares are lower today, breaking a trend of higher closes. The stock is trading with unusually high volume amid no specific news.

8 de set. de 2026, 20:07 UTC

Glaukos Corp shares are higher today, recovering from an early dip amid speculation of a potential interest rate hike following a strong jobs report.

1 de set. de 2026, 19:31 UTC

Glaukos Corp. shares are lower today amid broader market volatility and rising U.S. Treasury yields, continuing a three-session decline.

31 de ago. de 2026, 20:07 UTC

Glaukos Corp shares are lower amid broader market concerns over inflation and potential Fed rate hikes. Earlier, the stock rebounded from a session low.

28 de ago. de 2026, 20:07 UTC

Glaukos Corp shares are lower during Friday's session amid rising U.S. Treasury yields and broader market trends, with no specific company news identified.

27 de ago. de 2026, 20:07 UTC

Glaukos Corp. shares are higher amid broader market trends. A decline in initial jobless claims may support a positive outlook for health care stocks.

25 de ago. de 2026, 20:07 UTC

Glaukos Corp shares are lower today amid broader market declines, despite remaining above their 20-day moving average and near the top of their one-month range.

21 de ago. de 2026, 19:56 UTC

Glaukos Corp's shares are higher today, reflecting a cumulative gain since Thursday. The stock remains near the upper end of its one-month range.

20 de ago. de 2026, 20:06 UTC

Glaukos Corp. shares are lower today, reflecting a decline from Wednesday's close. The stock earlier pulled back after reaching a session high.

19 de ago. de 2026, 20:06 UTC

News

Glaukos Corp will present at the Wells Fargo Healthcare Conference on September 9, 2026, as shares gain during Wednesday's trading session.

14 de ago. de 2026, 19:46 UTC

Glaukos Corp. shares are lower today, reaching a session low amid broader market declines following a surprise drop in U.S. retail sales for July.

13 de ago. de 2026, 19:22 UTC

Glaukos Corp. shares are higher today amid unusually high trading volume. The stock remains significantly above its 20-day moving average.

12 de ago. de 2026, 19:16 UTC

Glaukos Corp shares are higher today, supported by overall strength in U.S. stocks and positive quarterly results from AI sector companies.

10 de ago. de 2026, 20:06 UTC

Glaukos Corp shares are higher today, following a broader market trend since Friday. Earlier, the stock reached a session high before pulling back.

7 de ago. de 2026, 20:02 UTC

Glaukos Corp shares are rising in Friday's session, supported by unusually high trading volume and a steady upward trend since Thursday's close.

4 de ago. de 2026, 19:36 UTC

Glaukos Corp shares are lower today, impacted by declines in the Health Care Equipment sub-sector. The stock pulled back after reaching an earlier high.

3 de ago. de 2026, 20:06 UTC

Glaukos Corp shares are higher amid positive market sentiment, with the S&P 500 and Nasdaq 100 also gaining. The stock remains above its 20-day moving average.

31 de jul. de 2026, 19:45 UTC

News

Glaukos shares are lower today despite H.C. Wainwright raising the price target to $195 from $168. Trading volume has been unusually high.

30 de jul. de 2026, 21:31 UTC

News

Glaukos Corp shares are lower in after-market trading, tracking declines in the Health Care Equipment sector. UBS raised its price target to $172.

29 de jul. de 2026, 21:22 UTC

Social Media
News

Glaukos Corp reported record net sales of $185.6 million in Q2 2026, raising its full-year revenue guidance to $680 million to $700 million. Shares are higher in after-market trading.

28 de jul. de 2026, 17:46 UTC

News

Glaukos Corp shares are lower after UBS initiated coverage with a Neutral rating, overshadowing Stifel's Buy rating and $175 price target.

Comparação entre Pares

Variação de preço

Glaukos Corp Previsão

Preço-alvo

By TipRanks

27.78% parte superior

Previsão para 12 meses

Média 197.333 USD  27.78%

Máximo 225 USD

Mínimo 172 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para Glaukos Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

13 ratings

12

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

254 / 339 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.